Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Total 13F shares
-
73,228,780
-
Share change
-
-14,842,594
-
Total reported value
-
$325,906,994
-
Put/Call ratio
-
145%
-
Price per share
-
$4.45
-
Number of holders
-
135
-
Value change
-
-$64,299,920
-
Number of buys
-
59
-
Number of sells
-
70
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2020
As of 31 Dec 2020,
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,228,780 shares.
The largest 10 holders included
FEDERATED HERMES, INC., STATE STREET CORP, BlackRock Inc., Chicago Capital, LLC, VANGUARD GROUP INC, Avidity Partners Management LP, PFM Health Sciences, LP, BLAIR WILLIAM & CO/IL, GOLDMAN SACHS GROUP INC, and Rock Springs Capital Management LP.
This page lists
135
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.